EUVIMEDEUVIMED entdecken
Crossref

L26/P-649 Diagnostic haplotype phasing using short- and long-read whole genome sequencing in preimplantation genetic testing for monogenic disorders (PGT-M) for prospective parents with de novo variants

M. Weerts, B. Yaldiz, J. Dreesen, N. Souren, J. Meekels, F. Snepvangers, M. Drusedau, W. Jamnongluk, M. Heijligers, B. De Koning, A. Van den Wijngaard, M. Zamani Esteki und 1 weitere

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.979 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von M. Weerts und 12 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question How do short- and long-read whole genome sequencing (srWGS, lrWGS) in PGT-M perform for prospective parents with a de novo pathogenic variant? Summary answer srWGS is successful in 9 out of 10 couples in pre-test and clinical cycle, lrWGS enables de novo variant phasing prior to the clinical cycle. What is known already Approximately 10% of prospective parents opting for PGT-M are carrying de novo pathogenic variants. For this group, the current ESHRE guidelines mandate direct detection of the variant in order to establish the phase (high-risk and low-risk haplotypes) either prior to or during the clinical PGT cycle. The use of srWGS offers high accuracy and facilitates generic (in)direct detection of variants, omitting the burden of time-consuming family-tailored multiplex-PCR protocols. Nevertheless, challenging genomic areas (e.g. telomere, centromere, GC-rich) are covered suboptimally, especially after multiple displacement amplification (MDA) of DNA. lrWGS covers these challenging loci and also offers direct phasing. Study design, size, duration Retrospective cohort study reviewing all couples with a (deemed) de novo pathogenic variant in one or both prospective parents, who underwent a haplarithmisis-based PGT-M pre-examination test between 2023 and 2025 in the Netherlands. As a pilot, a novel lrWGS approach for phasing of the de novo variant was applied in a selection of the couples. Participants/materials, setting, methods The haplarithmisis-based PGT pre-test included srWGS of the prospective parents and the affected partner’s parents (prospective grandparents). Direct variant detection was validated in srWGS data using three MDA few-cell lymphocyte samples, mimicking trophectoderm (TE) embryo biopsy, from the affected prospective parent(s). In the clinical cycle, the haplarithmisis-based srWGS test was used on MDA TE biopsies. For lrWGS, nanopore adaptive sampling was carried out for the affected partner. Main results and the role of chance A cohort of 83 couples including 34 (40%) males and 50 (60%) females (84 individuals) with a de novo pathogenic variant comprising 79 (94%) small nucleotide variants and 5 (6%) copy number variants. During test development, direct variant detection in the srWGS data was successful for 74 (88%) individuals, whereas for 10 (12%) individuals insufficient variant coverage in challenging genomic loci necessitated family-tailored variant detection multiplex-PCR protocols. Test development took twice as long when a tailored protocol was needed (srWGS: median 172 days (IQR 43), tailored: median 381 days (IQR 118)). The phase was established prior to the clinical cycle for 3 individuals carrying a deletion by using polymorphisms in the deleted area, and for 4 males using single sperm cell analysis. About half of the couples had a clinical cycle (42 (51%)). The phase was established in the first cycle for 39 (91%) couples, whereas for 3 (9%) couples the phase could not be established in the absence of clearly affected embryos. The novel lrWGS approach does not require embryos to establish the phase, and enabled direct phasing of the de novo pathogenic variant for all (100%) of the 7 tested individuals. Limitations, reasons for caution In this retrospective study, not all couples already proceeded to a clinical PGT cycle. Further validation and diagnostic implementation of the novel lrWGS approach is ongoing. Wider implications of the findings For prospective parents with a de novo pathogenic variant, the srWGS haplarithmisis-based PGT-M pre-examination test decreases turnaround time drastically. The novel lrWGS approach has the potential to consistently establish the phase of the de novo pathogenic variant prior to the clinical PGT cycle. Trial registration number No

Zitieren

APA

Weerts, M., Yaldiz, B., Dreesen, J., Souren, N., Meekels, J., Snepvangers, F., Drusedau, M., Jamnongluk, W., Heijligers, M., Koning, B. D., Wijngaard, A. V. D., Esteki, M. Z., & Paulussen, A. (2026). L26/P-649 Diagnostic haplotype phasing using short- and long-read whole genome sequencing in preimplantation genetic testing for monogenic disorders (PGT-M) for prospective parents with de novo variants. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.979

Vancouver

Weerts M, Yaldiz B, Dreesen J, Souren N, Meekels J, Snepvangers F, et al. L26/P-649 Diagnostic haplotype phasing using short- and long-read whole genome sequencing in preimplantation genetic testing for monogenic disorders (PGT-M) for prospective parents with de novo variants. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.979

BibTeX
@article{Weerts2026,
  author = {Weerts, M. and Yaldiz, B. and Dreesen, J. and Souren, N. and Meekels, J. and Snepvangers, F. and Drusedau, M. and Jamnongluk, W. and Heijligers, M. and Koning, B. De and Wijngaard, A. Van den and Esteki, M. Zamani and Paulussen, A.},
  title = {L26/P-649 Diagnostic haplotype phasing using short- and long-read whole genome sequencing in preimplantation genetic testing for monogenic disorders (PGT-M) for prospective parents with de novo variants},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.979}
}
Kostenlos starten →